Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2025-12-25 @ 1:03 AM
NCT ID:
NCT00264693
Eligibility Criteria:
Inclusion Criteria:
* Patient starting with dalteparin for prophylaxis OR therapy by order of the treating physician (after having evaluated clinical indication and contraindications).
* Renal function normal OR impaired with or without dialysis therapy according to open study groups
* Age \>= 18 years
* Written informed consent
Exclusion Criteria:
* Pregnancy / Lactation
* Dalteparin or other LMWH already in use for \> 1 day, unless just in use during hemodialysis
* Anti-Xa level before first application of dalteparin \> 0.3 U / ml
* Participation in another study
* Anuria OR glomerular filtration rate \< 10 ml/min without dialysis
* Patient on intensive care unit (ICU)
* Cardiovascular unstable patient or probable need for a quick stop of anticoagulation (e.g. emergency surgery)
* Patient with a disease whose estimated life expectancy is \< 28 days
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00264693
Study Brief:
Protocol Section:
NCT00264693